Additional PRINCe assessments detected a putative complex rearrangement affecting BRCA1 in a patient with mCRPC, along with clinically relevant copy-number alterations in advanced treatment-naïve patients with heavy tumor burden (Supplementary Figure 11; see Supplementary Results). This evidence concerns the gene BRCA1 and neoplasm.